Brochure
27 Oct 2021
APPLIVER FIBROSIS
PDF 713 kB
APPLIVER® is the new product obtained by the ABR innovative biotechnological platform NATRISE®.
Our research studies confirm the beneficial effect on health of APPLIVER® in metabolic disorder as NAFLD.
This makes APPLIVER® the perfect ingredient for dietary supplements and functional foods.
Content provided by our supplier
ABResearch srl
-
IT -
2020On CPHI since
-
3Certificates
-
25 - 49Employees
Company types
Other Content from ABResearch srl ()
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance